Literature DB >> 19079658

The Critical Role of TGF-beta1 in the Development of Induced Foxp3+ Regulatory T Cells.

Song Guo Zheng1.   

Abstract

Foxp3+T regulatory cell (Treg) subsets play a crucial role in the maintenance of immune homeostasis against self-antigen. The lack or dysfunction of these cells is responsible for the pathogenesis and development of many autoimmune diseases. Therefore, manipulation of these cells may provide a novel therapeutic approach to treat autoimmune diseases and prevent allograft rejection during organ transplantation. In the article, we will provide current opinions concerning the classification, developmental and functional characterizations of Treg subsets. A particular emphasis will be focused on transforming cell growth factor beta (TGF-beta) and its role in the differentiation and development of induced regulatory T cells (iTregs) in the periphery. Moreover, the similarity and disparity of iTregs and naturally occurring, thymus-derived CD4+CD25+Foxp3+ regulatory T cells (nTregs) will also be discussed. While proinflammatory cytokine IL-6 can convert nTregs to IL-17-producing cells, peripheral Tregs induced by TGF-beta are resistant to this cytokine. This difference may affect the role of each in the adaptive immune response.

Entities:  

Keywords:  Foxp3; Immunoregulation; TGF-β; Th17 cells; regulatory T cells

Year:  2008        PMID: 19079658      PMCID: PMC2592590     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  87 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo.

Authors:  M Hara; C I Kingsley; M Niimi; S Read; S E Turvey; A R Bushell; P J Morris; F Powrie; K J Wood
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.

Authors:  Guliang Xia; Jie He; Zheng Zhang; Joseph R Leventhal
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

4.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1970-05       Impact factor: 7.397

5.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Genetic susceptibility to post-thymectomy autoimmune diseases in mice.

Authors:  A Kojima; R T Prehn
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.

Authors:  V L Heath; E E Murphy; C Crain; M G Tomlinson; A O'Garra
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

8.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  18 in total

Review 1.  Why some organ allografts are tolerated better than others: new insights for an old question.

Authors:  Travis D Hull; Gilles Benichou; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

2.  Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function.

Authors:  Puneet Gaitonde; Aaron Peng; Robert M Straubinger; Richard B Bankert; Sathy V Balu-Iyer
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

Review 3.  Natural regulatory T cells in autoimmunity.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Autoimmunity       Date:  2010-11-23       Impact factor: 2.815

Review 4.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

Review 5.  FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance.

Authors:  Alessandro Alessandrini; Laurence A Turka
Journal:  Am J Kidney Dis       Date:  2016-12-31       Impact factor: 8.860

6.  Induction of antigen-specific immune tolerance by TGF-beta-induced CD4+Foxp3+ regulatory T cells.

Authors:  Huimin Fan; Julie Wang; Xiaohui Zhou; Zhongmin Liu; Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2009-08-25

7.  Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant.

Authors:  Stephanie M Coomes; Carol A Wilke; Thomas A Moore; Bethany B Moore
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

8.  T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.

Authors:  Mohammad Afzal Khan
Journal:  Mol Med       Date:  2016-11-22       Impact factor: 6.354

Review 9.  The effect of icariin on immunity and its potential application.

Authors:  Rong Shen; Ju-Hua Wang
Journal:  Am J Clin Exp Immunol       Date:  2018-06-05

10.  Potential regulatory role of in vitro-expanded Vδ1 T cells from human peripheral blood.

Authors:  Fang Hua; Ning Kang; Yun-An Gao; Lian-Xian Cui; De-Nian Ba; Wei He
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.